Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.

Abstract:

STUDY OBJECTIVE:To evaluate the efficacy and safety of a new combination product, enalapril-diltiazem ER, when administered over the long term. DESIGN:Open-label, titration to response, with treatment lasting 46 weeks after a 6-week, double-blind phase. SETTING:Medical clinics in the private and academic sectors. PATIENTS:Of 265 patients (68% men, 83% Caucasian, mean age 54.9 yrs) with essential hypertension (sitting diastolic blood pressure 95-115 mm Hg) enrolled, 167 completed the trial. INTERVENTIONS:Patients received either the dosage of enalapril-diltiazem ER that they were given during the double-blind phase, or were prescribed enalapril 5 mg-diltiazem ER 120 mg once/day. The dosage was increased until blood pressure was controlled or to a maximum of enalapril 10-diltiazem ER 360 mg/day. MEASUREMENTS AND MAIN RESULTS:Combination therapy decreased sitting blood pressures by -11.1/-10.6 mm Hg. Overall, 58% of the patients achieved a sitting diastolic blood pressure of 90 mm Hg or below at the end of the study. There was no evidence of tolerance to the agents' antihypertensive effects. The most common drug-related adverse events were cough, headache, dizziness, and asthenia or fatigue. CONCLUSION:The combination effectively managed essential hypertension when administered on a long-term basis and was generally well tolerated. It should improve both compliance and management of hypertension.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Applegate W,Cohen JD,Wolfson P,Davis A,Green S

subject

Has Abstract

pub_date

1997-01-01 00:00:00

pages

107-12

issue

1

eissn

0277-0008

issn

1875-9114

journal_volume

17

pub_type

临床试验,杂志文章,多中心研究,随机对照试验
  • Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.

    abstract::Neuroleptic malignant syndrome (NMS) is an idiosyncratic and uncommon but serious adverse effect that has been reported with both typical and atypical antipsychotic agents. We describe a 58-year-old man with Down syndrome and dementia who was receiving low-dose olanzapine and rivastigmine therapy; he developed NMS 4 m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.3.403

    authors: Stevens DL,Lee MR,Padua Y

    更新日期:2008-03-01 00:00:00

  • The place of selective serotonin reuptake inhibitors in the treatment of panic disorder.

    abstract::Panic disorder is a frequently chronic condition with extensive patterns of psychiatric comorbidity. Optimum pharmacotherapy with traditional agents is limited by side effects, long-term tolerability, and other problems. Recent research findings support the characterization of panic disorder as an illness involving de...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: DeVane CL

    更新日期:1997-03-01 00:00:00

  • Use of Newer Anticonvulsants for the Treatment of Status Epilepticus.

    abstract::Status epilepticus (SE) has a high mortality rate and is one of the most common neurologic emergencies. Fast progression of this neurologic emergency and lack of response to traditional antiepileptic drugs (AEDs) in most cases has challenged clinicians to use new agents. This article evaluates the efficacy and safety ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2229

    authors: Farrokh S,Bon J,Erdman M,Tesoro E

    更新日期:2019-03-01 00:00:00

  • Methotrexate in rheumatoid arthritis: an update.

    abstract::Methotrexate, a folic acid antagonist, is being employed more frequently in an attempt to control rheumatoid arthritis that has not responded adequately to conventional therapies. Systemic administration of 7.5-15 mg weekly in a pulse fashion appears to be effective without precipitating serious adverse effects. Conce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1986.tb03472.x

    authors: Miller DR,Letendre PW,DeJong DJ,Fiechtner JJ

    更新日期:1986-07-01 00:00:00

  • Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?

    abstract::Behavioral and psychological symptoms of dementia can occur in 60-80% of patients with Alzheimer's disease or other dementing illnesses, and are important in that they are a source of significant caregiver stress and often precipitate nursing home placement. These symptoms, namely, aggression, delusions, hallucination...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.1.74.34437

    authors: Rojas-Fernandez CH,Lanctot KL,Allen DD,MacKnight C

    更新日期:2001-01-01 00:00:00

  • Reversible akinetic mutism possibly induced by baclofen.

    abstract::A 76-year-old man developed akinetic mutism after 3 days of receiving low-dosage baclofen. Electroencephalography showed a diffusely slow background with intermittent generalized sharp wave discharges. The condition resolved after discontinuing baclofen. To our knowledge, this is the first reported case of baclofen-in...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.19.6.468.31053

    authors: Rubin DI,So EL

    更新日期:1999-04-01 00:00:00

  • Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management.

    abstract::Limitations of traditional anticoagulants have led to the need for structured services to provide anticoagulation monitoring. Anticoagulation management services have historically filled this role. Novel antithrombotic agents currently in development have the potential to improve on the limitations of vitamin K antago...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.15.199s.43159

    authors: Nutescu EA,Spinler SA,Dager WE,Bussey HI

    更新日期:2004-10-01 00:00:00

  • Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review.

    abstract::Central nervous system stimulants are a commonly used first-line treatment option for attention-deficit/hyperactivity disorder (ADHD). Stimulants are generally well tolerated, with anorexia and insomnia the most common adverse effects. However, there are some concerns with long-term use of stimulants, such as potentia...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2192

    authors: Troksa K,Kovacich N,Moro M,Chavez B

    更新日期:2019-06-01 00:00:00

  • Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners.

    abstract::Oral anticoagulation with warfarin requires routine monitoring of prothrombin time, expressed as the international normalized ratio (INR). Patient self-testing for INR is common in Europe but not in the United States. In order to determine the frequency of INR self-testing among patients whose anticoagulant therapy is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.2.265.56949

    authors: Wittkowsky AK,Sekreta CM,Nutescu EA,Ansell J

    更新日期:2005-02-01 00:00:00

  • Management of Pediatric Acute Hematogenous Osteomyelitis, Part II: A Focus on Methicillin-Resistant Staphylococcus aureus, Current and Emerging Therapies.

    abstract::Methicillin-resistant Staphylococcus aureus (MRSA) has become the most prevalent cause of acute hematogenous osteomyelitis (AHO) in pediatric patients. This increase in MRSA is due to the rise in community-acquired MRSA. Therefore, it is important that clinicians are aware of the various and upcoming therapies that co...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2164

    authors: DeRonde KJ,Girotto JE,Nicolau DP

    更新日期:2018-10-01 00:00:00

  • CYP2D6, N-acetylation, and xanthine oxidase activity in cystic fibrosis.

    abstract:STUDY OBJECTIVE:To determine the activity of CYP2D6, N-acetylation, and xanthine oxidase, three drug-metabolizing enzyme systems, in patients with cystic fibrosis and compare the findings with those in individuals without the disease. DESIGN:Prospective cohort study. SETTING:General pediatrics service. PATIENTS:Fift...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Bosso JA,Liu Q,Evans WE,Relling MV

    更新日期:1996-09-01 00:00:00

  • Maximizing the benefit of pharmacotherapy in Parkinson's disease.

    abstract::Levodopa is one of the principal agents administered to treat patients with Parkinson's disease (PD). Several pharmacologic strategies can limit its side effects and enhance its activity. Although certain exceptions apply, dosage adjustments and drug changes should be instituted slowly. Levodopa is typically introduce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.2.33s.34632

    authors: Berchou RC

    更新日期:2000-01-01 00:00:00

  • Trends in antimicrobial resistance among today's bacterial pathogens.

    abstract::Resistance of nosocomial and community-acquired pathogens to antimicrobial agents is a serious problem with significant clinical consequences. Microbiologic surveillance data, such as those provided by the National Nosocomial Infections Surveillance System, supply information on current nosocomial pathogens in the Uni...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Thornsberry C

    更新日期:1995-01-01 00:00:00

  • Clinical pharmacokinetic monitoring of midazolam in critically ill patients.

    abstract::Midazolam is a commonly used sedative in critically ill, mechanically ventilated patients in intensive care unit (ICU) settings worldwide. We used a nine-step decision-making algorithm to determine whether therapeutic monitoring of midazolam in the ICU is warranted. Midazolam has a higher clearance and shorter half-li...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.27.3.389

    authors: Spina SP,Ensom MH

    更新日期:2007-03-01 00:00:00

  • Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.

    abstract::Hypertension and diabetes appear to increase coronary heart disease risk in part by causing an abnormality in lipid metabolism. Most affected are patients with familial dyslipidemic hypertension (FDH) and noninsulin-dependent diabetes mellitus (NIDDM). The lipid disorders most often encountered in these patients are i...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: McKenney JM

    更新日期:1993-07-01 00:00:00

  • The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.

    abstract::Two analyses were conducted to compare the cost-effectiveness of different intravenous immunoglobulin (IGIV) formulations: IGIV purified by caprylate precipitation and chromatography (IGIV-C) and IGIV manufactured by an older solvent-detergent method (IGIV-S/D). The results indicated that IGIV-C is associated with cos...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.2005.25.11part2.94S

    authors: Mahadevia PJ

    更新日期:2005-11-01 00:00:00

  • Antimicrobial prophylaxis for arthroplasty and total joint replacement: discussion and review of published clinical trials.

    abstract::Cephalosporins are often administered to prevent infections that can follow total joint replacements (TJR) and other arthroplastic procedures. However, recommendations contained within published guidelines and review articles vary greatly from those given by the manufacturer in product information circulars. Similarly...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Heath AF

    更新日期:1991-01-01 00:00:00

  • Argatroban therapy for antithrombin deficiency and mesenteric thrombosis: case report and review of the literature.

    abstract::Antithrombin deficiency is a hypercoagulable state that can increase the risk for thrombosis, especially in the presence of other procoagulant triggers. Unfractionated heparin and low-molecular-weight heparins may not provide effective anticoagulation since they require antithrombin for activity. Direct thrombin inhib...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.6.659.34745

    authors: Dager WE,Gosselin RC,Owings JT

    更新日期:2004-05-01 00:00:00

  • Antimicrobial formulary management: a case study in a teaching hospital.

    abstract::The role of the formulary system for effective cost containment is becoming increasingly important. With antimicrobial agents taking up a large proportion of most pharmaceutical budgets, this group of agents is an obvious target for cost reduction. The responsible interchange of selected antimicrobial agents offers a ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Wright DB

    更新日期:1991-01-01 00:00:00

  • Benzalkonium Chloride: A Bronchoconstricting Preservative in Continuous Albuterol Nebulizer Solutions.

    abstract::For convenience, many pediatric hospitals are preparing solutions for continuous nebulized albuterol using the 0.5% 20-ml multidose albuterol dropper bottle. This product contains benzalkonium chloride (BAC) that, by itself, produces bronchospasm that is dose dependent and cumulative. The bronchoconstrictive effects o...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1929

    authors: Prabhakaran S,Abu-Hasan M,Hendeles L

    更新日期:2017-05-01 00:00:00

  • Accuracy of 2- and 8-hour urine collections for measuring creatinine clearance in the hospitalized elderly.

    abstract::The accuracy of 2- and 8- hour urine collections for estimating creatinine clearance was compared with that of the standard 24-hour procedure in 45 hospitalized elderly patients (age > or = 65 yrs) with indwelling urethral catheters. Urine was collected at blocked intervals from 0-2, 2-8, and 8-24 hours and then added...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: O'Connell MB,Wong MO,Bannick-Mohrland SD,Dwinell AM

    更新日期:1993-03-01 00:00:00

  • Tacrolimus toxicity associated with concomitant metoclopramide therapy.

    abstract::Subtherapeutic tacrolimus trough concentrations were noted in a 52-year-old woman who had undergone liver transplantation. Her tacrolimus dosage was increased from 7 to 28 mg twice/day, and ketoconazole therapy was added; however, her tacrolimus concentration remained undetectable. Metoclopramide 10 mg 4 times/day was...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.5.532.33357

    authors: Prescott WA Jr,Callahan BL,Park JM

    更新日期:2004-04-01 00:00:00

  • Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin.

    abstract::Fluoxetine hydrochloride is the sixth most prescribed drug in the United States and is administered to treat major depression. A cadaveric skin donation was obtained from a 46-year-old woman who died as a result of a fluoxetine overdose. Due to the potential penetration of the drug and its major metabolite, norfluoxet...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Neudeck BL,Taddonio TE,Garner WL,Welage LS

    更新日期:1998-07-01 00:00:00

  • Adverse reactions associated with systemic polymyxin therapy.

    abstract::The systemic polymyxins, colistin and polymyxin B, are increasingly used for multidrug-resistant bacterial infections and have a long history of dose-limiting toxicity. This review summarizes the most recent available information about the mechanisms, incidence, risk factors, and minimization strategies for polymyxin ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1493

    authors: Justo JA,Bosso JA

    更新日期:2015-01-01 00:00:00

  • Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.

    abstract::Prostaglandins have been shown to relax the smooth muscle of the ductus arteriosus in the fetus in utero. This physiologic action has been applied to the management of newborn infants with certain types of congenital malformations. Infants with lesions producing right ventricular outflow obstruction have a compromised...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1982.tb04522.x

    authors: Heymann MA,Clyman RI

    更新日期:1982-05-01 00:00:00

  • Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient.

    abstract::A 38-year-old woman with type 1 diabetes underwent kidney-pancreas transplantation. Her postoperative course was complicated due to recurrent acute graft rejections and pancreatitis. After initial immunosuppression with microemulsion cyclosporine, mycophenolate mofetil, and prednisone with muromonab-CD3 induction, cyc...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.19.10.891.31562

    authors: Min DI,Ku YM,Rayhill S,Corwin C,Wu YM,Hunsicker LG

    更新日期:1999-07-01 00:00:00

  • Key articles and guidelines in the management of hypertension: 2008 update.

    abstract::Hypertension remains a major risk factor for cardiovascular disease. The optimal choice of pharmacologic and nonpharmacologic treatment regimens is based on a plethora of published literature. This compilation is the initial update to the Key Articles and Guidelines in the Management of Hypertension authored by member...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.8.1041

    authors: Gaffney SM,de Denus S,Olson KL,Ripley TL,Robinette B,Summers KM,Spencer AP

    更新日期:2008-08-01 00:00:00

  • Influence of coadministration of fluoxetine on cisapride pharmacokinetics and QTc intervals in healthy volunteers.

    abstract:STUDY OBJECTIVE:To evaluate the effect of fluoxetine on the pharmacokinetics and cardiovascular safety of cisapride at steady state in healthy men. DESIGN:Open-label, three-phase, sequential study. SETTING:Clinical research center. SUBJECTS:Twelve healthy male volunteers. INTERVENTIONS:Each subject was treated acco...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.21.2.149.34109

    authors: Zhao Q,Wojcik MA,Parier JL,Pesco-Koplowitz L

    更新日期:2001-02-01 00:00:00

  • Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.

    abstract:STUDY OBJECTIVE:To assess the reproducibility of Naranjo Adverse Drug Reaction Probability Scale (APS) scores in published case reports. DESIGN:Reliability analysis. MEASUREMENTS AND MAIN RESULTS:Randomly selected case reports using the APS were identified from the Web of Science database. The APS scores were blinded...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1496

    authors: Liang R,Borgundvaag B,McIntyre M,Thwaites C,Ragan K,Wyllie A

    更新日期:2014-11-01 00:00:00

  • Adjunctive Use of Cidofovir and Intravenous Immunoglobulin to Treat Invasive Adenoviral Disease in Solid Organ Transplant Recipients.

    abstract:BACKGROUND:Infections with adenoviruses (ADVs) can result in considerable mortality and morbidity in solid organ transplant (SOT) recipients. Standard therapy for ADV infections in transplant recipients is not established. At our institution, intravenous cidofovir and immunoglobulin have been used to treat disseminated...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2194

    authors: Permpalung N,Mahoney MV,Alonso CD

    更新日期:2018-12-01 00:00:00